These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 32187470)

  • 61. Acute abdomen in a patient with homozygous type I hereditary angioedema: rapid improvement in computed tomography scans after C1 inhibitor replacement.
    Jáuregui Presa I; Varona Peinador M; Pérez Bea M; Ruiz-Ogarrio MC; Gamboa Setién PM; García Lirio E; Soriano Galarraga AM; Antépara Ercoreca I; Ortiz de Zárate MM
    J Investig Allergol Clin Immunol; 2013; 23(7):504-6. PubMed ID: 24654315
    [No Abstract]   [Full Text] [Related]  

  • 62. Upper airway considerations in hereditary angioedema.
    Papadopoulou-Alataki E
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):20-5. PubMed ID: 19949324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of pdC1-INH concentrate for long-term prophylaxis during pregnancy in hereditary angioedema with normal C1-INH.
    Garcia JFB; Takejima P; Veronez CL; Aun MV; Motta AA; Kalil J; Pesquero JB; Giavina-Bianchi P
    J Allergy Clin Immunol Pract; 2018; 6(4):1406-1408. PubMed ID: 29439936
    [No Abstract]   [Full Text] [Related]  

  • 64. Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
    Wasserman RL; Levy RJ; Bewtra AK; Hurewitz D; Craig TJ; Kiessling PC; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):62-8. PubMed ID: 21195947
    [TBL] [Abstract][Full Text] [Related]  

  • 65. rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency.
    Varga L; Farkas H
    Expert Rev Clin Immunol; 2011 Mar; 7(2):143-53. PubMed ID: 21426252
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hereditary angioedema: treatment, management, and precautions in patients presenting for dental care.
    Van Sickels NJ; Hunsaker RB; Van Sickels JE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):168-72. PubMed ID: 20123405
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K; Tholanikunnel TE; Kaplan AP
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A roadmap for optimal care of the patient with hereditary angioedema.
    Castaldo AJ; Riedl MA; Settipane RA; Bellanti JA
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S01-S02. PubMed ID: 33109316
    [No Abstract]   [Full Text] [Related]  

  • 69. New Treatments for Hereditary Angioedema.
    Johnson NM; Phillips MA
    Skin Therapy Lett; 2018 Jan; 23(1):6-8. PubMed ID: 29357215
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Kinin formation in C1 inhibitor deficiency.
    Kaplan AP; Joseph K
    J Allergy Clin Immunol; 2010 Jun; 125(6):1411-2; author reply 1412. PubMed ID: 20381848
    [No Abstract]   [Full Text] [Related]  

  • 71. Hereditary angioedema and COVID-19 during pregnancy: Two case reports.
    Salih A; Chin A; Gandhi M; Shamshirsaz A; Lombaard H; Hajjar J
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):961-962. PubMed ID: 36572180
    [No Abstract]   [Full Text] [Related]  

  • 72. The Effectiveness and Value of Lanadelumab and C1 Esterase Inhibitors for Prophylaxis of Hereditary Angioedema Attacks.
    Agboola F; Lubinga S; Carlson J; Lin GA; Dreitlein WB; Pearson SD
    J Manag Care Spec Pharm; 2019 Feb; 25(2):143-148. PubMed ID: 30698087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. C1-esterase inhibitor for short-term prophylaxis in a patient with hereditary angioedema with normal C1 inhibitor function.
    Yu SK; Callum J; Alam A
    J Clin Anesth; 2016 Dec; 35():488-491. PubMed ID: 27871580
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Usefulness of C1 esterase inhibitor protein concentrate in the management of hereditary angioedema of oropharyngeal tissue.
    Yigit M; Sogut O; Lisar H; Yigit E
    Niger J Clin Pract; 2018 Apr; 21(4):531-533. PubMed ID: 29607870
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Delayed diagnosis of hereditary angioedema: Thirty-nine years of inadequate treatment.
    Martinez-Saguer I; Escuriola Ettingshausen C
    Ann Allergy Asthma Immunol; 2016 Nov; 117(5):554-556. PubMed ID: 27593101
    [No Abstract]   [Full Text] [Related]  

  • 76. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
    Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
    J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.
    Wu MA; Castelli R
    Clin Chem Lab Med; 2016 Feb; 54(2):207-14. PubMed ID: 26068904
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Current and emerging biologics for the treatment of hereditary angioedema.
    Perego F; Wu MA; Valerieva A; Caccia S; Suffritti C; Zanichelli A; Bergamaschini L; Cicardi M
    Expert Opin Biol Ther; 2019 Jun; 19(6):517-526. PubMed ID: 30912460
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prophylactic therapy in children with hereditary angioedema.
    Farkas H; Csuka D; Zotter Z; Varga L; Füst G
    J Allergy Clin Immunol; 2013 Feb; 131(2):579-82.e1-2. PubMed ID: 23014586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.